RxDoctor Payments Data

Nyal Borges, MD

Interventional Cardiology · Charlotte, NCNPI 1790042448

Payments from drug & device makers

$29,844in general payments, 2019–2025

Across 375 payments — averaging $79.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$11K
  • Boston Scientific$8K
  • Shockwave Medical, Inc$4K
  • Abiomed$2K
  • Medtronic$915
  • Teleflex LLC$676
  • plus $3K from 18 others
$108in research payments, 2019–2025

Across 1 payment — averaging $108.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$108

What the payments were for

  • Travel & lodging$6,70437%
  • Food & beverage$11,52763%
  • Education$1021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,844 in reported general payments places this provider in the 65th percentile of 180 interventional cardiology providers in North Carolina.

See all interventional cardiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$199,827
Medicare patients
370
Services billed
1,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban72$79,353
Praluent PenAlirocumab23$27,008
Repatha SureclickEvolocumab25$22,716
Ranolazine ErRanolazine46$5,608
ClopidogrelClopidogrel Bisulfate323$3,856
Ezetimibe129$2,389
Isosorbide Mononitrate ErIsosorbide Mononitrate102$2,111
Atorvastatin Calcium167$1,746
Metoprolol Succinate130$1,654
Rosuvastatin Calcium60$1,018
Losartan Potassium79$789
Amlodipine Besylate74$480
Carvedilol51$413
Spironolactone26$285
Chlorthalidone12$230

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →